ArticleApplied biochemistry and biotechnology2025
Artificial Neural Network-Based Validation, DFT, Thermal and Biological Evaluation of 4-Aminoantipyrine-Derived Ru(III) Complexes.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New methodologies have been evaluated for validating analytical characterization with artificial neural networks (ANNs). Compared to previous machine learning models, these provide more accurate and automated results with high testing accuracy. The Schiff base ruthenium complexes used in the proposed study were synthesized using 4-aminoantipyrine derivatives. 4-Aminoantipyrine is a biologically active pharmacophore. The geometry of the complexes was confirmed by IR, electronic, and magnetic measurements. XRD analysis pointed out the nanocrystalline behavior of the chelates. The molecular structures have been optimized using DFT calculations. The ruthenium complexes are one of the main chemotherapeutic agents in anticancer therapy over platinum drugs due to a wide range of peculiarities. Complexes exhibit octahedral geometry as confirmed by magnetic measurements exhibiting more biological activity. The complexes are redox active depicting high biological potency. The Ru chelates also display high photocatalytic efficiency. The chelates also adhere to Lipinski's rule of five as evidenced from mole inspiration calculations. Among the chelates, RuL
Indexed as
Identifiers
39821503What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.